Try our Advanced Search for more refined results
Life Sciences - May, 2005
29 articles
- Branded Drug Makers Face Increasingly Aggressive Challenges By Generic Makers, Study Finds
- Tercica, Genentech File Motion To Block Insmed Growth Therapy
- Sanofi Legal Honcho Quits As Plavix Trial Nears
- Israel's Planned Patent Overhaul Raises E.U. Concerns
- Court Slaps Medtronic With Injunction In Biomet Patent Case
- U.K. Court Refuses To Dismiss Patent Suit Over Growth Hormone
- Knorr-Bremse Case Puts Spotlight On St. Onge
- Jones Day Eyes China, Japan For Further IP Growth
- Bristol-Myers Loses Canadian Court Battle Over Taxol Alternative
- Zimmer To Pay $17M To Settle BTG Patent Suit
- With Huge Payout To Surgeon, Medtronic Ends Costly Patent Dispute
- Federal Circuit Lets Apotex Challenge Acular Patent Again
- Pfizer Says China Used Wrong Standards In Overturning Viagra Patent
- Japan Mulls Longer Drug Patents
- DC OKs Controversial Compulsory Licensing Bill
- Astellas, Boehringer Sue Ranbaxy Over Flomax ANDA
- Patent Reform Hot Potatoes
- Delaware District Court Hears Sanofi-Aventis Trademark Suit Vs. Advancis Pharma
- Blue Cross, Blue Shield Sue Glaxo For Paxil Patent Gaming
- Federal Circuit Upholds Verdict Vs. Smith & Nephew In Patent Suit, Revives Antitrust Suit Vs. ArthroCare
- Glaxo, Bentley Settle Patent Suit Over Paxil In Spanish Court
- IBM Hires IP Guru Rivette For New Strategy Post
- Lilly ICOS Targets Online Cialis Sales With ITC Complaint
- Skadden IP Group Takes Upstart Approach Despite Elite Reputation
- Judge Delays Plavix Trial Once More
- Senators Introduce Bill To Extend Patent Rights For Biodefense Drugs
- Andrx, Amphastar Pen Deal For Generic Lovenox
- Cephalon Drops Patent Suit Vs. Sandoz Over Provigil
- Finnegan Henderson Defies "Boutique" Label